Ashraf Khalil

1.6k total citations
37 papers, 1.2k citations indexed

About

Ashraf Khalil is a scholar working on Molecular Biology, Organic Chemistry and Neurology. According to data from OpenAlex, Ashraf Khalil has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Organic Chemistry and 6 papers in Neurology. Recurrent topics in Ashraf Khalil's work include Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (8 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Ashraf Khalil is often cited by papers focused on Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (8 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Ashraf Khalil collaborates with scholars based in Qatar, United States and Canada. Ashraf Khalil's co-authors include Neal Castagnoli, Dale E. Edmondson, Claudia Binda, Kristoffer Valerie, Sarah E. Golding, Ala‐Eddin Al Moustafa, Elizabeth Rosenberg, Andrea Mattevi, František Hubálek and Lawrence F. Povirk and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Ashraf Khalil

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashraf Khalil Qatar 17 641 340 206 163 113 37 1.2k
Jichun Ma United States 12 463 0.7× 283 0.8× 206 1.0× 235 1.4× 90 0.8× 19 1.1k
Chen Yao China 21 643 1.0× 320 0.9× 101 0.5× 99 0.6× 71 0.6× 77 1.4k
Fengtian Xue United States 27 738 1.2× 595 1.8× 181 0.9× 95 0.6× 104 0.9× 90 1.9k
Arun Upadhyay India 23 971 1.5× 201 0.6× 260 1.3× 140 0.9× 115 1.0× 50 1.9k
Pierfausto Seneci Italy 24 1.2k 1.8× 706 2.1× 147 0.7× 167 1.0× 94 0.8× 109 2.0k
Mitsuru Ohkubo Japan 23 783 1.2× 631 1.9× 311 1.5× 98 0.6× 154 1.4× 60 1.5k
Sophia Schedin‐Weiss Sweden 20 844 1.3× 177 0.5× 81 0.4× 198 1.2× 170 1.5× 62 1.6k
Paul C. Trippier United States 21 802 1.3× 827 2.4× 149 0.7× 224 1.4× 123 1.1× 55 1.8k
Hwayoung Yun South Korea 20 686 1.1× 382 1.1× 557 2.7× 101 0.6× 35 0.3× 80 1.8k
Heeyeong Cho South Korea 20 578 0.9× 466 1.4× 140 0.7× 222 1.4× 89 0.8× 65 1.5k

Countries citing papers authored by Ashraf Khalil

Since Specialization
Citations

This map shows the geographic impact of Ashraf Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf Khalil more than expected).

Fields of papers citing papers by Ashraf Khalil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf Khalil. The network helps show where Ashraf Khalil may publish in the future.

Co-authorship network of co-authors of Ashraf Khalil

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf Khalil. A scholar is included among the top collaborators of Ashraf Khalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf Khalil. Ashraf Khalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suliman, Ahmed, et al.. (2025). Liposomal delivery of DK14 chalcone analogue: A promising therapeutic strategy against triple-negative breast cancer. Journal of Drug Delivery Science and Technology. 115. 107601–107601. 1 indexed citations
2.
Alali, Feras Q., et al.. (2025). The Role of Natural Chalcones and Their Derivatives in Targeting Prostate Cancer: Recent Updates. International Journal of Molecular Sciences. 26(24). 12082–12082.
3.
Allouch, Asma, et al.. (2024). The effect of novel nitrogen-based chalcone analogs on colorectal cancer cells: Insight into the molecular pathways. Heliyon. 10(5). e27002–e27002. 3 indexed citations
4.
Awaisu, Ahmed, et al.. (2023). Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials. Frontiers in Oncology. 13. 1251895–1251895. 5 indexed citations
6.
Zagho, Moustafa M., et al.. (2020). Recent advances in stimuli-responsive drug release and targeting concepts using mesoporous silica nanoparticles. Emergent Materials. 3(3). 407–425. 49 indexed citations
7.
Alali, Feras Q., et al.. (2020). Novel Polymethoxylated Chalcones as Potential Compounds Against KRAS-Mutant Colorectal Cancers. Current Pharmaceutical Design. 26(14). 1622–1633. 9 indexed citations
8.
Moustafa, Ala‐Eddin Al, et al.. (2020). A comprehensive review on the antiviral activities of chalcones. Journal of drug targeting. 29(4). 403–419. 99 indexed citations
9.
Siddique, Abu Bakar, Farhan Cyprian, Khalid A. El Sayed, et al.. (2019). Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer. European Journal of Medicinal Chemistry. 187. 111954–111954. 42 indexed citations
10.
Petzer, Jacobus P., Anél Petzer, Usman Ashraf, et al.. (2019). SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 863–876. 50 indexed citations
11.
Alali, Feras Q., et al.. (2018). Targeting triple negative breast cancer heterogeneity with chalcones: a molecular insight. Journal of drug targeting. 27(8). 830–838. 17 indexed citations
12.
Aboulkassim, Tahar, et al.. (2018). Teucrium Polium Plant Extract Provokes Substantial Cytotoxicity at the Early Stage of Embryonic Development. SHILAP Revista de lepidopterología. 19(1). 67–71. 10 indexed citations
13.
Khalil, Ashraf, et al.. (2015). Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson’s Disease. CNS & Neurological Disorders - Drug Targets. 14(6). 777–785. 30 indexed citations
14.
Muhammad, Sajjad, Elizabeth Rosenberg, Jason M. Beckta, et al.. (2013). ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation. Clinical Cancer Research. 19(12). 3189–3200. 150 indexed citations
15.
Hawkins, Amy J., Sarah E. Golding, Ashraf Khalil, & Kristoffer Valerie. (2011). DNA double-strand break – induced pro-survival signaling. Radiotherapy and Oncology. 101(1). 13–17. 38 indexed citations
16.
Metwally, Kamel, Ashraf Khalil, Harris Pratsinis, & Dimitris Kletsas. (2010). Synthesis, in‐vitro Cytotoxicity, and a Preliminary Structure‐Activity Relationship Investigation of Pyrimido[4,5‐c]quinolin‐1(2H)‐ones. Archiv der Pharmazie. 343(8). 465–472. 7 indexed citations
17.
Rimoldi, John M., et al.. (2005). A novel and selective monoamine oxidase B substrate. Bioorganic & Medicinal Chemistry. 13(20). 5808–5813. 8 indexed citations
18.
Hubálek, František, Claudia Binda, Ashraf Khalil, et al.. (2005). Demonstration of Isoleucine 199 as a Structural Determinant for the Selective Inhibition of Human Monoamine Oxidase B by Specific Reversible Inhibitors. Journal of Biological Chemistry. 280(16). 15761–15766. 193 indexed citations
19.
Golding, Sarah E., Elizabeth Rosenberg, Ashraf Khalil, et al.. (2004). Double Strand Break Repair by Homologous Recombination Is Regulated by Cell Cycle-independent Signaling via ATM in Human Glioma Cells. Journal of Biological Chemistry. 279(15). 15402–15410. 98 indexed citations
20.
Castagnoli, Kay, Stefanus J. Steyn, Géraldine Magnin, et al.. (2002). Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase. Neurotoxicity Research. 4(2). 151–160. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026